Anti-factor Xa kinetics after intravenous enoxaparin in patients undergoing percutaneous coronary intervention: a population model analysis.

Item

http://www.wikidata.org/entity/Q35826954

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Anti-factor Xa kinetics after ...... : a population model analysis.

@ast

Anti-factor Xa kinetics after ...... : a population model analysis.

@en

type

Item

label

Anti-factor Xa kinetics after ...... : a population model analysis.

@ast

Anti-factor Xa kinetics after ...... : a population model analysis.

@en

prefLabel

Anti-factor Xa kinetics after ...... : a population model analysis.

@ast

Anti-factor Xa kinetics after ...... : a population model analysis.

@en

P1476

Anti-factor Xa kinetics after ...... : a population model analysis.

@en

P2093

Annick Ankri

http://www.w3.org/2001/XMLSchema#string

Jean-Philippe Collet

http://www.w3.org/2001/XMLSchema#string

Jean-Sébastien Hulot

http://www.w3.org/2001/XMLSchema#string

Paola Sanchez-Pena

http://www.w3.org/2001/XMLSchema#string

Philippe Lechat

http://www.w3.org/2001/XMLSchema#string

Saïk Urien

http://www.w3.org/2001/XMLSchema#string

P2860

Application of current guidelines to the management of unstable angina and non-ST-elevation myocardial infarction

Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes

Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide

Percutaneous coronary intervention after subcutaneous enoxaparin pretreatment in patients with unstable angina pectoris.

American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acut

Antithrombotic therapy in patients undergoing percutaneous coronary intervention.

The role of low-molecular-weight heparins in the management of unstable angina and non-ST-segment elevation myocardial infarction.

Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.

Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months.

Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE).

P304

364-373

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2125.2005.02452.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gilles Montalescot

Rémi Choussat

Saïk Urien

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7576439

http://www.w3.org/2001/XMLSchema#string

P698

16187968

http://www.w3.org/2001/XMLSchema#string

P932

1884830

http://www.w3.org/2001/XMLSchema#string